By Josh White
Date: Wednesday 08 Jul 2026
(Sharecast News) - Avacta Therapeutics said on Wednesday it had appointed healthcare executive Patrick Vink to its board as non-executive deputy chairman and senior independent director.
Vink is currently chairman of Arch Biopartners, Micreos Group, Secura Bio and F2G, and sits on the board of Spero Therapeutics.
Chief executive Christina...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news